Home

Amyloid-beta

Alzheimer's Disease

Read time: 7 min

Using neuroimaging to investigate Alzheimer’s disease heterogeneity

In this symposium, titled ‘Neuropsychological assessment for different populations: from...

Alzheimer's Disease

Read time: 7 min

Tau neuropathology in Alzheimer’s disease and other neurodegenerative conditions

In this symposium titled ‘Human Neuropathology: Tau, a key protein in the human brain,...

Alzheimer's Disease

Read time: 2 min

Congress highlights

What’s happening in the brain in Alzheimer’s disease and dementia?

The brains of people with Alzheimer’s disease contain abnormal proteins—amyloid-beta...

Alzheimer's Disease

Read time: 2 min

Satellite symposium

Implications of an early diagnosis of Alzheimer’s disease

Early diagnosis of Alzheimer’s disease provides patients and their families with the...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Plasma P-tau promises diagnostic accuracy and prediction of cognitive decline

Extraordinary advances in plasma tau biomarkers, and especially in P-tau217, offer to aid...

Alzheimer's Disease

Read time: 4 min

Congress highlights

The AT(N) system for classifying Alzheimer’s disease biologically

The AT(N) research framework for identifying and staging participants in Alzheimer’s disease...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Which tau biomarkers are most informative in AD?

Aggregates of hyperphosphorylated and C-terminally truncated microtubule-associated tau protein are...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease?

The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of...

Alzheimer's Disease

Read time: 5 min

Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease?

Amyloid-beta (Aβ) accumulation in Alzheimer’s Disease (AD) may, in part, be due to an...

Alzheimer's Disease

Read time: 4 min

New insights into Apolipoprotein E and Alzheimer’s Disease

Apolipoprotein E4 is a major risk factor for Alzheimer’s Disease and is strongly related to...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country